share_log

通化东宝(600867.SH)累计回购1.17%股份 完成第二期股份回购计划

Tonghua Dongbao Pharmaceutical (600867.SH) has repurchased a cumulative 1.17% of its shares, completing the second phase of its share repurchase plan.

Zhitong Finance ·  Jan 2 17:25

Tonghua Dongbao Pharmaceutical (600867.SH) announced that by December 31, 2024, the company will complete 2024...

According to a report from the Zhixing Finance APP, Tonghua Dongbao Pharmaceutical (600867.SH) announced that by December 31, 2024, the company completed the second phase of share repurchase for 2024, and the share repurchase plan has been fully implemented. A total of 23.1912 million shares were repurchased, accounting for 1.17% of the company's total equity. The highest repurchase price was 8.45 yuan per share, the lowest price was 7.32 yuan per share, and the average repurchase price was 7.76 yuan per share, with a total funding amount of 0.18 billion yuan (excluding transaction fees).

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment